These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33495337)

  • 21. GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes.
    Karhu ST; Kinnunen SM; Tölli M; Välimäki MJ; Szabó Z; Talman V; Ruskoaho H
    Arch Toxicol; 2020 Jun; 94(6):2113-2130. PubMed ID: 32185414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation.
    Ichikawa Y; Ghanefar M; Bayeva M; Wu R; Khechaduri A; Naga Prasad SV; Mutharasan RK; Naik TJ; Ardehali H
    J Clin Invest; 2014 Feb; 124(2):617-30. PubMed ID: 24382354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct contribution of Rac1 expression in cardiomyocytes to anthracycline-induced cardiac injury.
    Henninger C; Pohlmann S; Ziegler V; Ohlig J; Schmitt J; Fritz G
    Biochem Pharmacol; 2019 Jun; 164():82-93. PubMed ID: 30936017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment.
    Chaudhari U; Nemade H; Wagh V; Gaspar JA; Ellis JK; Srinivasan SP; Spitkovski D; Nguemo F; Louisse J; Bremer S; Hescheler J; Keun HC; Hengstler JG; Sachinidis A
    Arch Toxicol; 2016 Nov; 90(11):2763-2777. PubMed ID: 26537877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
    Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity.
    Guo R; Hua Y; Ren J; Bornfeldt KE; Nair S
    Cell Death Dis; 2018 Jun; 9(6):692. PubMed ID: 29880809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of CACNA1H attenuates doxorubicin-induced acute cardiotoxicity by affecting endoplasmic reticulum stress.
    Hu J; Wu Q; Wang Z; Hong J; Chen R; Li B; Hu Z; Hu X; Zhang M
    Biomed Pharmacother; 2019 Dec; 120():109475. PubMed ID: 31580970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity.
    Koleini N; Santiago JJ; Nickel BE; Sequiera GL; Wang J; Fandrich RR; Jassal DS; Dhingra S; Kirshenbaum LA; Cattini PA; Kardami E
    Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H279-H288. PubMed ID: 30412444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxiredoxin-1 Overexpression Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Oxidative Stress and Cardiomyocyte Apoptosis.
    Jiang L; Gong Y; Hu Y; You Y; Wang J; Zhang Z; Wei Z; Tang C
    Oxid Med Cell Longev; 2020; 2020():2405135. PubMed ID: 32802259
    [No Abstract]   [Full Text] [Related]  

  • 31. Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain.
    Gasser PJ; Orchinik M; Raju I; Lowry CA
    J Comp Neurol; 2009 Feb; 512(4):529-55. PubMed ID: 19025979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
    Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
    Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S100A8 and S100A9 Are Associated with Doxorubicin-Induced Cardiotoxicity in the Heart of Diabetic Mice.
    Pei XM; Tam BT; Sin TK; Wang FF; Yung BY; Chan LW; Wong CS; Ying M; Lai CW; Siu PM
    Front Physiol; 2016; 7():334. PubMed ID: 27547188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes.
    Upadhyay S; Mantha AK; Dhiman M
    J Ethnopharmacol; 2020 Aug; 258():112690. PubMed ID: 32105749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfer of metformin across the rat placenta is mediated by organic cation transporter 3 (OCT3/SLC22A3) and multidrug and toxin extrusion 1 (MATE1/SLC47A1) protein.
    Ahmadimoghaddam D; Staud F
    Reprod Toxicol; 2013 Aug; 39():17-22. PubMed ID: 23562376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
    Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
    Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-212/132 Cluster Modulation Prevents Doxorubicin-Mediated Atrophy and Cardiotoxicity.
    Gupta SK; Garg A; Avramopoulos P; Engelhardt S; Streckfuss-Bömeke K; Batkai S; Thum T
    Mol Ther; 2019 Jan; 27(1):17-28. PubMed ID: 30527757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-noncoding RNA MALAT1 sponges microRNA-92a-3p to inhibit doxorubicin-induced cardiac senescence by targeting ATG4a.
    Xia W; Chen H; Xie C; Hou M
    Aging (Albany NY); 2020 May; 12(9):8241-8260. PubMed ID: 32384281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner.
    Durham KK; Kluck G; Mak KC; Deng YD; Trigatti BL
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1447-H1457. PubMed ID: 31002281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes.
    Zhao L; Zhang B
    Sci Rep; 2017 Mar; 7():44735. PubMed ID: 28300219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.